AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34689783 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal test and treat (UTT) strategy access
Number of subjects: 71
Study 34689783 — intervention group
Group type: COMPARATOR
Intervention: Control communities without access to UTT
Number of subjects: 71
Study 34195765 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia with postoperative epidural analgesia
Number of subjects: 1802
Study 34195765 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with postoperative intravenous analgesia
Number of subjects: 1802
Study 34195765 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 1802
Study 34195765 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1802
Study 32001384 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM/P-15 (mixed 50/50, 5cc/level)
Number of subjects: 101
Study 32001384 — intervention group
Group type: COMPARATOR
Intervention: Allograft bone (30 g/level)
Number of subjects: 101
Study 32001384 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM/P-15 and Allograft
Number of subjects: 101
Study 33838348 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 420
Study 33838348 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 420
Study 32008619 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-based TEE training
Number of subjects: 71
Study 32008619 — intervention group
Group type: COMPARATOR
Intervention: Web-based TEE training
Number of subjects: 71
Study 35315885 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic 40% dextrose gel (n=681)
Number of subjects: 1359
Study 35315885 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (n=678)
Number of subjects: 1359
Study 35315885 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic 40% dextrose gel
Number of subjects: 1359
Study 35315885 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 1359
Study 34201703 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate
Number of subjects: 9
Study 34201703 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice protein isolate
Number of subjects: 9
Study 34201703 — intervention group
Group type: COMPARATOR
Intervention: Potato protein isolate
Number of subjects: 9
Study 34201703 — intervention group
Group type: EXPERIMENTAL
Intervention: All proteins
Number of subjects: 9
Study 33053024 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus dexamethasone (20mg IV once daily for 5 days, then 10mg IV once daily for additional 5 days or until ICU discharge)
Number of subjects: 350
Study 33053024 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without dexamethasone (Control Group)
Number of subjects: 350
Study 33712022 — intervention group
Group type: EXPERIMENTAL
Intervention: Eat Well @ IGA intervention (trolley and basket signage, local area and in-store promotion, shelf tags for healthiest packaged foods)
Number of subjects: 500
Study 33712022 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff perceptions of the Eat Well @ IGA intervention
Number of subjects: 500
Study 33712022 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder collaboration in intervention design and implementation
Number of subjects: 500
Study 33712022 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-listed stores)
Number of subjects: 500
Study 33087372 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban school children
Number of subjects: 854
Study 33087372 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural school children
Number of subjects: 854
Study 33087372 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall school children
Number of subjects: 854
Study 33087372 — intervention group
Group type: COMPARATOR
Intervention: Place of residence (urban vs rural)
Number of subjects: 854
Study 35883180 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized blood pressure management (MAP maintained within 10% of the first MAP measured before EVT)
Number of subjects: 432
Study 35883180 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure management (SBP maintained within 140-180 mm Hg until reperfusion or artery closure)
Number of subjects: 432
Study 35883180 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized blood pressure management
Number of subjects: 432
Study 32335963 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Public Transportation/Active Commuting (IG-PT, N = 25)
Number of subjects: 73
Study 32335963 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Cycling (IG-C, N = 26)
Number of subjects: 73
Study 32335963 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG, N = 22)
Number of subjects: 73
Study 35130299 — intervention group
Group type: EXPERIMENTAL
Intervention: VE (Violence prevention + Education)
Number of subjects: 2075
Study 35130299 — intervention group
Group type: EXPERIMENTAL
Intervention: VEHW (Violence prevention + Education + Health + Wealth)
Number of subjects: 2075
Study 35130299 — intervention group
Group type: COMPARATOR
Intervention: V-only (Violence prevention only)
Number of subjects: 2075
Study 32790868 — intervention group
Group type: EXPERIMENTAL
Intervention: Effect size Correlation for COnfounding determination (ECCO)
Number of subjects: 0
Study 32790868 — intervention group
Group type: COMPARATOR
Intervention: Standard approach for determining optimal number of PEER factors
Number of subjects: 0
Study 32790868 — intervention group
Group type: EXPERIMENTAL
Intervention: ECCO
Number of subjects: 0
Study 35598000 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured educational intervention based on the rational perception of postoperative pain and discomfort (anchoring and improved pain scale), and the proper use of analgesics
Number of subjects: 414
Study 35598000 — intervention group
Group type: COMPARATOR
Intervention: Standard information on post-discharge pain management
Number of subjects: 414
Study 33723790 — intervention group
Group type: EXPERIMENTAL
Intervention: Synolis VA (80 mg hyaluronic acid and 160 mg sorbitol)
Number of subjects: 202
Study 33723790 — intervention group
Group type: COMPARATOR
Intervention: Synvisc-One (48 mg hylan GF-20)
Number of subjects: 202
Study 33723790 — intervention group
Group type: EXPERIMENTAL
Intervention: Synolis VA
Number of subjects: 202
Study 33723790 — intervention group
Group type: COMPARATOR
Intervention: Synvisc-One
Number of subjects: 202
Study 33989539 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-antigenic hepatitis B vaccine (TAV) - 10 μg, administered intramuscularly on days 0, 28, and 168.
Number of subjects: 1607
Study 33989539 — intervention group
Group type: COMPARATOR
Intervention: Mono-antigenic hepatitis B vaccine (MAV) - 20 μg, administered intramuscularly on days 0, 28, and 168.
Number of subjects: 1607
Study 33374575 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gel containing diclofenac sodium, methyl salicylate, and lyophilized Calendula officinalis
Number of subjects: 115
Study 34082075 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily self-weighing (DSW) with instruction to weigh daily and provision of a web-enabled digital scale with graphical weight feedback
Number of subjects: 400
Study 34082075 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (receive a monetary gift card equivalent to value of the scale)
Number of subjects: 400
Study 35415742 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper-and-pencil-based cognitive training
Number of subjects: 81
Study 35415742 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation care (Control)
Number of subjects: 81
Study 33824890 — intervention group
Group type: EXPERIMENTAL
Intervention: SP-Lecturer group (n=28)
Number of subjects: 144
Study 33824890 — intervention group
Group type: EXPERIMENTAL
Intervention: RP-Tutor group (n=44)
Number of subjects: 144
Study 33824890 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 144
Study 34786815 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (< 120 mm Hg)
Number of subjects: 517
Study 34786815 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control (< 140 mm Hg)
Number of subjects: 517
Study 32718912 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg plus clopidogrel 75 mg daily
Number of subjects: 2590
Study 32718912 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg plus ticagrelor 90 mg twice daily
Number of subjects: 2590
Study 34432358 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 14
Study 34432358 — intervention group
Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 14
Study 32384261 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Foot Exercise (SFE)
Number of subjects: 3
Study 32384261 — intervention group
Group type: COMPARATOR
Intervention: Towel-curl exercise
Number of subjects: 3
Study 34330460 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet (intervention group, n = 122)
Number of subjects: 244
Study 34330460 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 122)
Number of subjects: 244
Study 32738349 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth periodontal debridement (FMPD)
Number of subjects: 26
Study 32738349 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue-assisted photodynamic therapy (PDT) with FMPD
Number of subjects: 26
Study 35475696 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop systems
Number of subjects: 0
Study 35475696 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm for diabetes care
Number of subjects: 0
Study 35475696 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated insulin delivery systems
Number of subjects: 0
Study 35475696 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support systems
Number of subjects: 0
Study 35300957 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 32
Study 35300957 — intervention group
Group type: COMPARATOR
Intervention: Conventional Osteotomy
Number of subjects: 32
Study 34534923 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine 4 mg/kg via local infiltration at the end of spine surgery (age group 1)
Number of subjects: 65
Study 34534923 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine 4 mg/kg via local infiltration at the end of spine or cardiac surgery (age group 2)
Number of subjects: 65
Study 34534923 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride (HCl) 2 mg/kg via local infiltration at the end of spine surgery (age group 1)
Number of subjects: 65
Study 34991769 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition notification based on virtual reality technology
Number of subjects: 60
Study 34991769 — intervention group
Group type: COMPARATOR
Intervention: Written explanations (Control)
Number of subjects: 60
Study 32050911 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norms and social support as measured by the Health Literacy Questionnaire and Control Preference Scale.
Number of subjects: 133
Study 32050911 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support scores
Number of subjects: 133
Study 32050911 — intervention group
Group type: EXPERIMENTAL
Intervention: Alignment on decision-making roles
Number of subjects: 133
Study 33094466 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C (3.0 g dissolved in 5% dextrose, 100 ml/time, 2 times/day)
Number of subjects: 117
Study 33094466 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine therapy with intravenous drip of 5% dextrose and placebo, 100 ml/time, 2 times/day)
Number of subjects: 117
Study 33094466 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C
Number of subjects: 117
Study 33094466 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 33065302 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue scraper, full mouth disinfection, and single application of PDT (Group II)
Number of subjects: 40
Study 33065302 — intervention group
Group type: COMPARATOR
Intervention: Tongue scraper and full mouth disinfection (Group I)
Number of subjects: 40
Study 33065302 — intervention group
Group type: EXPERIMENTAL
Intervention: Single application of PDT (Group II)
Number of subjects: 40
Study 35656983 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline neutrophil-to-lymphocyte ratio (NLR)
Number of subjects: 5881
Study 35656983 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in NLR between baseline and 1 year
Number of subjects: 5881
Study 33602197 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP using EGCG solution as coolant
Number of subjects: 20
Study 33602197 — intervention group
Group type: COMPARATOR
Intervention: SRP using distilled water as coolant (Control)
Number of subjects: 20
Study 33219056 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 521
Study 33219056 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant chemotherapy
Number of subjects: 521
Study 35270822 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher training in healthy eating and physical activity
Number of subjects: 7
Study 33206194 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal and predelivery models
Number of subjects: 502648
Study 33206194 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery and postdelivery models
Number of subjects: 502648
Study 33206194 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth weight as a predictor
Number of subjects: 502648
Study 33206194 — intervention group
Group type: EXPERIMENTAL
Intervention: Models incorporating 4 other top predictors
Number of subjects: 502648
Study 34696030 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent 10 min exposure/rest intervals during VR gaming
Number of subjects: 25
Study 34696030 — intervention group
Group type: COMPARATOR
Intervention: Continuous VR gaming without breaks
Number of subjects: 25
Study 32333328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Caffeine 100 mg FDC
Number of subjects: 562
Study 32333328 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 562
Study 32333328 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 100 mg
Number of subjects: 562
Study 32333328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study 35363799 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCUS (mindfulness-based stress management program)
Number of subjects: 0
Study 35363799 — intervention group
Group type: COMPARATOR
Intervention: Healthy Living (HL; active control)
Number of subjects: 0
Study 35363799 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (EC; usual care)
Number of subjects: 0
Study 33317988 — intervention group
Group type: EXPERIMENTAL
Intervention: QFT-GIT antigen tubes
Number of subjects: 21
Study 33317988 — intervention group
Group type: EXPERIMENTAL
Intervention: QFT-plus tubes
Number of subjects: 21
Study 33317988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nil tubes
Number of subjects: 21
Study 33317988 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1RA in GIT Ag tubes
Number of subjects: 21
Study 35299680 — intervention group
Group type: EXPERIMENTAL
Intervention: Karelizumab
Number of subjects: 100
Study 35299680 — intervention group
Group type: COMPARATOR
Intervention: SRS
Number of subjects: 100
Study 33951036 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean delivery kits (CDKs) including gloves, cord clamps, plastic sheets, and razor blades.
Number of subjects: 36996
Study 32611737 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 312
Study 32611737 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)/6-mercaptopurine (6MP)
Number of subjects: 312
Study 32611737 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (ADA)
Number of subjects: 312
Study 36188432 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1/temozolomide plus thalidomide
Number of subjects: 140
Study 36188432 — intervention group
Group type: COMPARATOR
Intervention: S-1/temozolomide
Number of subjects: 140
Study 35601970 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) administered in the morning (AM) before 10 am
Number of subjects: 35
Study 35601970 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide (TMZ) administered in the evening (PM) after 8 pm
Number of subjects: 35
Study 32106713 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized follow-up with an app for one year
Number of subjects: 113
Study 32106713 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 113
Study 36335323 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm (OTCMS with interventions)
Number of subjects: 12
Study 36335323 — intervention group
Group type: COMPARATOR
Intervention: Control arm (OTCMS without interventions)
Number of subjects: 12
Study 32279919 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 927
Study 32279919 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate II (HMII)
Number of subjects: 927
Study 33920642 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal steroid spray + BSE
Number of subjects: 47
Study 33920642 — intervention group
Group type: COMPARATOR
Intervention: Nasal steroid spray + placebo tablet
Number of subjects: 47
Study 33920642 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline nasal spray + BSE
Number of subjects: 47
Study 33920642 — intervention group
Group type: COMPARATOR
Intervention: Saline nasal spray + placebo tablet
Number of subjects: 47
Study 33920642 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid + BSE
Number of subjects: 47
Study 32406312 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (3900 mg Na+/day)
Number of subjects: 20
Study 32406312 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 20
Study 32406312 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 20
Study 36462139 — intervention group
Group type: EXPERIMENTAL
Intervention: High-supervision group (20 supervised sessions with an Exercise Professional over 12 weeks)
Number of subjects: 60
Study 36462139 — intervention group
Group type: COMPARATOR
Intervention: Low-supervision group (5 sessions over 12 weeks)
Number of subjects: 60
Study 33419909 — intervention group
Group type: EXPERIMENTAL
Intervention: Ada app-based diagnostic tool
Number of subjects: 0
Study 33419909 — intervention group
Group type: COMPARATOR
Intervention: Classical doctor-patient interaction
Number of subjects: 0
Study 33419909 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 32473797 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% potassium nitrate
Number of subjects: 43
Study 35804491 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstructive surgery using bone substitute material
Number of subjects: 138
Study 35804491 — intervention group
Group type: COMPARATOR
Intervention: Access flap surgery (control group)
Number of subjects: 138
Study 33787169 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular combined lower limb elastic compression device
Number of subjects: 40
Study 33787169 — intervention group
Group type: COMPARATOR
Intervention: Modified Robert Jones bandage of 3M elastic bandage
Number of subjects: 40
Study 33341180 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention
Number of subjects: 460
Study 33341180 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention with alcohol content
Number of subjects: 460
Study 33341180 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention with alcohol and cannabis content
Number of subjects: 460
Study 33341180 — intervention group
Group type: COMPARATOR
Intervention: Historical, information-only, sexual risk reduction control arm
Number of subjects: 460
Study 32040470 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed explanation about The Wand system
Number of subjects: 68
Study 32040470 — intervention group
Group type: COMPARATOR
Intervention: No specific information about The Wand system (Control)
Number of subjects: 68
Study 35652244 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 509
Study 35652244 — intervention group
Group type: COMPARATOR
Intervention: SSZ + HCQ
Number of subjects: 509
Study 33027800 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (MNT) for 12 weeks, involving 6 appointments with registered dietitians.
Number of subjects: 130
Study 33027800 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (MNT) group
Number of subjects: 130
Study 33027800 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 130
Study 35259767 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral cardiac rehabilitation program (BCR)
Number of subjects: 249
Study 35259767 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation program (CCR)
Number of subjects: 249
Study 32603531 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (FBX)
Number of subjects: 60
Study 32603531 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 60
Study 35761769 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent SCS (Perm group)
Number of subjects: 176
Study 35761769 — intervention group
Group type: COMPARATOR
Intervention: Temporary SCS (Temp group)
Number of subjects: 176
Study 33349509 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin group (PRFG)
Number of subjects: 15
Study 33349509 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate combined with platelet-rich fibrin group (BM/PG)
Number of subjects: 15
Study 33349509 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study 35705150 — intervention group
Group type: COMPARATOR
Intervention: Fluid restriction (1500 mL/day)
Number of subjects: 0
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted atrial fibrillation (AF)
Number of subjects: 0
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined resting heart rate
Number of subjects: 0
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: P-wave terminal force in the precordial lead V1 (PTFVI)
Number of subjects: 0